Skip to main content
Veterinary Medicines

KAOPECTATE SUSPENSION BUVABLE POUR EQUINS BOVINS OVINS PORCINS CHIENS ET CHATS

Authorised
  • KAOLIN, HEAVY
  • PECTIN

Product identification

Medicine name:
KAOPECTATE SUSPENSION BUVABLE POUR EQUINS BOVINS OVINS PORCINS CHIENS ET CHATS
Active substance:
  • KAOLIN, HEAVY
  • PECTIN
Target species:
  • Cattle (calf)
  • Horse (foal)
  • Pig (piglet)
  • Cat
  • Sheep (lamb)
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • KAOLIN, HEAVY
    197.20
    milligram(s)
    /
    1.00
    millilitre(s)
  • PECTIN
    4.40
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Cattle (calf)
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Horse (foal)
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Pig (piglet)
      • Meat and offal
        0
        day
    • Cat
    • Sheep (lamb)
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07BC30
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Purna Pharmaceuticals
Responsible authority:
  • National Veterinary Medicines Agency
Authorisation number:
  • FR/V/2731701 3/1990
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 16/01/2024

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 16/01/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."